drugset / Trial / NCT05756556
T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the efficacy and safety of T3011 in combination with Cobimetinib in patients with advanced melanoma.
Timeline
- Start
- 2024-06-30
- Primary completion
- 2026-12-31
- Completion
- 2027-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cobimetinib | Small molecule | 60 mg | Oral |
| Subject | T3011 | Other / unclassified | 1e+08 unknown | Other |